Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |